Drugmakers race to find a place in the next wave of obesity drugs
—·3h
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
ChannelsstocksCountriesusaCategoriespharma
Open original source ↗Published
6/13/2026, 12:00:01 PM
Fetched
6/13/2026, 12:07:17 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en